There’s a big reason why this company’s shares are on the move

This was just released

This is an Advertisement from our trusted sponsors

This company just announced its industry leading drug formulation and delivery business strategy for 2021. As a bioscience accelerator at the forefront of the life science industry, this company targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for extreme value creation. This company is paving the way in the drug formulation industry as their wholly owned subsidiary positions themselves for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions. Further to a press release earlier this month, the Company's core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine. Click here to read more about this inventive company that's making a major impact.

7322437 Canada Inc has been retained by InvestingChannel, a third party, to perform promotional and advertising services for 48 hours, with respect to the company we are profiling or discussing on this website or in this email, and in exchange for such services has received cash compensation of up to $3,500. Questions regarding this website may be sent to admin@financialmediamarketing.com 7322437 Canada Inc DOES NOT own any shares of the company mentioned. The principles and employees of 7322437 Canada Inc DO NOT own shares in the company mentioned. Advertisement: This is a paid advertisement from a 3rd party advertiser, for a product or service that is not offered, recommended or endorsed by us and for which claims have not been independently verified. Content: All of the content on our website and in our emails is for informational and illustrative purposes only, and should not be construed as an offer, or solicitation of an offer to buy or sell securities. You should always consult with a licensed securities professional before purchasing or selling securities. 7322437 Canada (DBA as Financial Media Marketing) (collectively, the "Company" or "we" used herein) bears no responsibility or control over the content of the advertisement and/or the product or service offered. Results: Any results shown are strictly hypothetical, and were executed in simulated trading accounts. CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN. Earnings Disclaimer: Our website, blogs and emails use affiliate and advertising programs for monetization, which means when you open, read, click on ads or links, will result in a commission that is credited to our company. Compliance: All header and reply-to information is accurate; you may reply directly to this email or send your reply to the physical address or email listed below. Subject lines reflect the content of the email and the email is clearly identified as an advertisement. All opt-outs are automatically honored and managed by the system. When profiling a specific company / stock or publicly traded company: 7322437 Canada Inc (DBA as Financial Media Marketing) has been retained by a third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing, In exchange for such services we have or will receive cash compensation from the third party. Questions regarding this may be sent to admin@financialmediamarketing.com Any information regarding a company profiled or discussed on this website or email is provided from public sources. And we make no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Our Principals, employees or affiliates may have a position or effect transactions in the securities described herein (or options thereon) and /or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. Why are you receiving this email: You are receiving this email because you are subscribed and have requested to receive newsletters from Financial Media Marketing. Please note that Financial Media Marketing will deliver emails to your from several or all of our brands, which will show as different From Names in the emails you receive. You can click here for a list of all our newsletter publications and From Names from which you will receive emails. Contact: For more information please contact us directly: 7322437 Canada Inc (Financial Media Marketing), 663 Ave Orly, Dorval, Quebec. H9P1G1. Our privacy policy can be found here If you no longer want to receive any email from us, you can remove yourself from ALL newsletters using this this form. Your unique contact ID 605b93f649bb0326138b456f. Today is Thursday.

In order to unsubscribe from this mailing list, please click here